Hot View Biotech (688068.SH) released its 2023 annual performance forecast and is expected to achieve ownership in 2023...
According to Zhitong Finance App News, Hot View Biotech (688068.SH) released its 2023 annual performance forecast. It is expected to achieve net profit of 24 million yuan to 36 million yuan attributable to the owner of the parent company in 2023. Compared with the same period last year (statutory disclosure data), it will decrease by 90,8736,600 yuan to 920.7366 million yuan, a year-on-year decrease of 96.19% to 97.46%.